Survival, exercise capacity, and left ventricular remodeling in a rat model of chronic mitral regurgitation: Serial echocardiography and pressure-volume analysis

Korean Circulation Journal

Volumn 41, Issue 10, 2011, Pages 603-611

  Kim, Kyung Hee ^a   Kim, Yong Jin ^a   Lee, Seung Pyo ^a   Kim, Hyung Kwan ^a   Seo, Jeong Wook ^a   Sohn, Dae Won ^a   Oh, Byung Hee ^a   Park, Young Bae ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Exercise test; Hemodynamic study; Mitral regurgitation; Rat model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE REMODELING; HEMODYNAMIC PARAMETERS; HISTOLOGY; MITRAL VALVE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; NONHUMAN; PATHOPHYSIOLOGY; PERIODIC MEDICAL EXAMINATION; PRESSURE VOLUME CURVE; RAT; SURVIVAL RATE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREADMILL EXERCISE;

EID: 82055193579     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2011.41.10.603     Document Type: Article

References (28)

1. Eriksson H. Heart failure: a growing public health problem. J Intern Med 1995;237:135-41.
2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-46. (Pubitemid 47311002)
3. Patten RD, Hall-Porter MR. Small animal models of heart failure: development of novel therapies, past and present. Circ Heart Fail 2009;2:138-44.
4. Monnet E, Chachques JC. Animal models of heart failure: what is new? Ann Thorac Surg 2005;79:1445-53. (Pubitemid 40431897)
5. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 2008;3:1422-34.
6. Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999;83:897-902, Erratum in: Am J Cardiol 1999;84:1143. (Pubitemid 29143128)
7. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JJ, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11. (Pubitemid 44353666)
8. Zheng J, Chen Y, Pat B, et al. Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog. Circulation 2009;119:2086-95.
9. Mishra YK, Mittal S, Jaguri P, Trehan N. Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. Ann Thorac Surg 2006;81:42-6. (Pubitemid 41815369)
10. Pu M, Gao Z, Li J, Sinoway L, Davidson WR Jr. Development of a new animal model of chronic mitral regurgitation in rats under transesophageal echocardiography guidance. J Am Soc Echocardiogr 2005;18:468-74. (Pubitemid 40704586)
11. Reffelmann T, Kloner RA. Transthoracic echocardiography in rats: evolution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging. Basic Res Cardiol 2003;98:275-84. (Pubitemid 37107654)
12. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy: chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation. 1995;91:2642-54.
13. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-83. (Pubitemid 17234556)
14. Chang SA, Kim YJ, Lee HW, et al. Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy. Hypertension 2009;54:591-7.
15. Lips DJ, van der Nagel T, Steendijk P, et al. Left ventricular pressure-volume measurements in mice: comparison of closed-chest versus open-chest approach. Basic Res Cardiol 2004;99:351-9. (Pubitemid 39236725)
16. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. American J Physiol Heart Circ Physiol 2005;289:H501-12. (Pubitemid 41129360)
17. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001;104:346-51. (Pubitemid 32666959)
18. Monnet E, Chachques JC. Animal models of heart failure: What is new? Ann Thorac Surg 2005;79:1445-53. (Pubitemid 40431897)
19. Daimon M, Shiota T, Gillinov AM, et al. Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real-time three-dimensional echocardiographic study in an ovine model. Circulation 2005;111:2183-9. (Pubitemid 40632433)
20. Chaput M, Handschumacher MD, Guerrero JL, et al. Mitral leaflet adaptation to ventricular remodeling: prospective changes in a model of ischemic mitral regurgitation. Circulation 2009;120(11 Suppl):S99-103.
21. Pu M, Gao Z, Zhang X, et al. Impact of mitral regurgitation on left ventricular anatomic and molecular remodeling and systolic function: implication for outcome. Am J Physiol Heart Circ Physiol 2009;296:H1727-37.
22. Zile MR, Tomita M, Nakano K, et al. Effects of left ventricular volume overload produced by mitral regurgitation on diastolic function. Am J Physiol 1991;261:H1471-80.
23. Corin WJ, Murakami T, Monrad ES, Hess OM, Krayenbuehl HP. Left ventricular passive diastolic properties in chronic mitral regurgitation. Circulation 1991;83:797-807.
24. Ryan TD, Rothstein EC, Aban I, et al. Left ventricular eccentric re-modeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 2007;49:811-21. (Pubitemid 46240707)
25. Weber KT, Pick R, Silver MA, et al. Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation 1990;82:1387-401.
26. Michel JB, Salzmann JL, Ossondo Nlom M, Bruneval P, Barres D, Camilleri JP. Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol 1986;81:142-54. (Pubitemid 16111890)
27. Pacher P, Mabley JG, Liaudet L, et al. Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure. Am J Physiol Heart Circ Physiol 2004;287:H2132-7. (Pubitemid 39430753)
28. Bátkai S, Pacher P, Osei-Hyiaman D, et al. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 2004;110:1996-2002. (Pubitemid 39331913)